ZNF521 and acute lymphoblastic leukemia: It could thus be hypothesized that if the MLL-AF9+ LICs follow the B-ALL pathway, the expression of ZNF521 is progressively attenuated by B-lymphoid regulatory factors that are known to repress its transcription including IKAROS [113], EBF1 [70], and possibly PAX5 [84].